MBQ Pharma
San Juan, US
MBQ Pharma develops precision therapeutics that target Rac and CDC42 GTPases for cancer, autoimmune, and fibrotic diseases, with a lead compound (MBQ-167) aimed at preventing and removing metastases. Its lead candidate is in a Phase 1 study, based on IP licensed from the University of Puerto Rico.
Founders & leadership
SD
SURANGANIE DHARMAWARDHANEChief Scientific Officer
CV
CORNELIS VLAARChief Development Officer
CA
CARLOS A DOMINGUEZChief Financial Officer
JF
JOSE F RODRIGUEZ-ORENGOChief Business Officer
FG
FEDERICO GOODSAIDChief Executive Officer
EH
ELIUD HERNANDEZChief Operating Officer
Board
AG
ARTURO GONZALEZBoard of Directors Member
HG
HUMBERTO GUZMANBoard of Directors Member
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 5 rounds · 2018–2026
▶$1.5MraisedAug 2026 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedAug 2026 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- CARLOS A DOMINGUEZExecutive Officer
- JOSE F RODRIGUEZ-ORENGOExecutive Officer
- SURANGANIE DHARMAWARDHANEExecutive Officer, Director
- FEDERICO GOODSAIDExecutive Officer, Director
- CORNELIS VLAARExecutive Officer, Director
- ELIUD HERNANDEZExecutive Officer
- Amount sold
- $1.5M
- First sale
- Jun 2018
- Incorporated
- Corporation, Puerto Rico
- Federal exemptions
- 06b
▶$882KraisedAug 2026 · 3 investors · PharmaceuticalsRule 506(b)
▶$882KraisedAug 2026 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- CARLOS A DOMINGUEZExecutive Officer
- JOSE F RODRIGUEZ-ORENGOExecutive Officer, Director
- SURANGANIE DHARMAWARDHANEExecutive Officer
- FEDERICO GOODSAIDExecutive Officer, Director
- CORNELIS VLAARExecutive Officer, Director
- ELIUD HERNANDEZExecutive Officer
- ARTURO GONZALEZDirector
- HUMBERTO GUZMANDirector
- Offering amount
- $882K
- Amount sold
- $882K
- First sale
- Feb 2021
- Incorporated
- Corporation, Puerto Rico
- Federal exemptions
- 06b
▶$325KraisedAug 2026 · 3 investors · PharmaceuticalsRule 506(b)
▶$325KraisedAug 2026 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- CARLOS A DOMINGUEZExecutive Officer
- JOSE F RODRIGUEZ-ORENGOExecutive Officer, Director
- SURANGANIE DHARMAWARDHANEExecutive Officer
- FEDERICO GOODSAIDExecutive Officer, Director
- CORNELIS VLAARExecutive Officer, Director
- ELIUD HERNANDEZExecutive Officer
- ARTURO GONZALEZDirector
- HUMBERTO GUZMANDirector
- Offering amount
- $325K
- Amount sold
- $325K
- First sale
- Mar 2022
- Incorporated
- Corporation, Puerto Rico
- Federal exemptions
- 06b
▶$500KraisedAug 2026 · 2 investors · PharmaceuticalsRule 506(b)
▶$500KraisedAug 2026 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- CARLOS A DOMINGUEZExecutive Officer
- JOSE F RODRIGUEZ-ORENGOExecutive Officer, Director
- SURANGANIE DHARMAWARDHANEExecutive Officer
- FEDERICO GOODSAIDDirector
- CORNELIS VLAARDirector
- ARTURO GONZALEZDirector
- HUMBERTO GUZMANDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Aug 2023
- Incorporated
- Corporation, Puerto Rico
- Federal exemptions
- 06b
▶$991KraisedAug 2026 · 8 investors · PharmaceuticalsRule 506(b)
▶$991KraisedAug 2026 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- CARLOS A DOMINGUEZExecutive Officer, Director
- JOSE F RODRIGUEZ-ORENGOExecutive Officer, Director
- SURANGANIE DHARMAWARDHANEExecutive Officer
- ARTURO GONZALEZDirector
- NEIL SANKARExecutive Officer
- Amount sold
- $991K
- First sale
- May 2026
- Incorporated
- Corporation, Puerto Rico
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapBioQ Pharma8 shared keywordsBioQ Pharma is a pharmaceutical company with expertise in biotech development and healthcare technology. The company appears to be focused on pharmaceutical innovation with a board of directors drawn from senior executives with extensive experience in biotech, medical devices, and pharma commercialization.
ResQ Pharma6 shared keywordsResQ Pharma is a pharmaceutical company developing LipidRescue (LRT), an investigational lipid-based drug therapy that is pending FDA approval. The company works on biologics development, regulatory affairs, and clinical research for its drug candidate.
STAQ Pharma6 shared keywordsSTAQ Pharma is an FDA-registered 503B outsourcing facility that compounds and supplies medications to hospitals and healthcare providers across the United States, aiming to address drug shortages. The company is owned and guided by several healthcare systems and focuses on safety, transparency, availability, and quality.
Companies competing with MBQ Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does MBQ Pharma do?
- MBQ Pharma develops precision therapeutics that target Rac and CDC42 GTPases for cancer, autoimmune, and fibrotic diseases, with a lead compound (MBQ-167) aimed at preventing and removing metastases. Its lead candidate is in a Phase 1 study, based on IP licensed from the University of Puerto Rico.
- Who founded MBQ Pharma?
- MBQ Pharma was founded by SURANGANIE DHARMAWARDHANE, CORNELIS VLAAR.
- How much funding has MBQ Pharma raised?
- MBQ Pharma has disclosed $4.2M raised across 5 rounds.
- Where is MBQ Pharma headquartered?
- MBQ Pharma is headquartered in San Juan, US.